Hungary is the 2nd most popular site for clinical trials in the CEE region, after Poland.

Hungary has…

• 250-300 registered trials annually;
• Regulatory approval period of only 9 weeks;
• Rapid recruitment for Multiple Indications;
• The University of Szeged, with a strong reputation for industry collaboration and innovation, which hosts one of Europe’s most advanced research centres.